Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03303339
Title PCM-075 in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Trovagene, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California Los Angeles Los Angeles California 90095 United States Details
Yale University New Haven Connecticut 06510 United States Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Allina Health Virginia Piper Cancer Institute Minneapolis Minnesota 55407 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Cancer Specialists - Fairfax Office Fairfax Virginia 22031 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field